13 results
8-K
EX-10.1
LRMR
Larimar Therapeutics Inc
30 Oct 20
Entry into a Material Definitive Agreement
5:02pm
all liabilities, injuries, losses, claims, damages (whether punitive, special, consequential or otherwise), settlements, attorneys’ and consultants
8-K/A
EX-99.2
LRMR
Larimar Therapeutics Inc
26 Jun 20
Other Events
5:08pm
, or as the use ofCTI-1601 becomes more widespread if it receives regulatory approval, illnesses, injuries, discomforts and other adverse events that were
DEFM14A
sf1yh
29 Apr 20
Proxy related to merger
3:20pm
PRER14A
qhrjyiqemc eq
10 Apr 20
Preliminary revised proxy
4:38pm
PREM14A
11zb7 gh105nd
6 Mar 20
Preliminary proxy related to merger
5:32pm
10-Q
rl9um 6riemp8qnf
14 Aug 14
Quarterly report
12:00am
- Prev
- 1
- Next